Structural Basis for 2′-5′-Oligoadenylate Binding and Enzyme Activity of a Viral RNase L Antagonist

被引:21
|
作者
Ogden, Kristen M. [1 ]
Hu, Liya [2 ]
Jha, Babal K. [3 ]
Sankaran, Banumathi [4 ]
Weiss, Susan R. [5 ]
Silverman, Robert H. [3 ]
Patton, John T. [1 ]
Prasad, B. V. Venkataram [2 ]
机构
[1] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
[2] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA
[3] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA
[4] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA
[5] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
DOUBLE-STRANDED-RNA; L PATHWAY; ROTAVIRUS; PROTEIN; 2'-PHOSPHODIESTERASE; PHOSPHODIESTERASE; IDENTIFICATION; REPLICATION; SYNTHETASE; ACTIVATION;
D O I
10.1128/JVI.00701-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Synthesis of 2'-5'-oligoadenylates (2-5A) by oligoadenylate synthetase (OAS) is an important innate cellular response that limits viral replication by activating the latent cellular RNase, RNase L, to degrade single-stranded RNA. Some rotaviruses and corona-viruses antagonize the OAS/RNase L pathway through the activity of an encoded 2H phosphoesterase domain that cleaves 2-5A. These viral 2H phosphoesterases are phylogenetically related to the cellular A kinase anchoring protein 7 (AKAP7) and share a core structure and an active site that contains two well-defined H Phi(S/T)Phi (where Phi is a hydrophobic residue) motifs, but their mechanism of substrate binding is unknown. Here, we report the structures of a viral 2H phosphoesterase, the C-terminal domain (CTD) of the group A rotavirus (RVA) VP3 protein, both alone and in complex with 2-5A. The domain forms a compact fold, with a concave beta-sheet that contains the catalytic cleft, but it lacks two alpha-helical regions and two beta-strands observed in AKAP7 and other 2H phosphoesterases. The cocrystal structure shows significant conformational changes in the R loop upon ligand binding. Bioinformatics and biochemical analyses reveal that conserved residues and residues required for catalytic activity and substrate binding comprise the catalytic motifs and a region on one side of the binding cleft. We demonstrate that the VP3 CTD of group B rotavirus, but not that of group G, cleaves 2-5A. These findings suggest that the VP3 CTD is a streamlined version of a 2H phosphoesterase with a ligand-binding mechanism that is shared among 2H phosphodiesterases that cleave 2-5A. IMPORTANCE The C-terminal domain (CTD) of rotavirus VP3 is a 2H phosphoesterase that cleaves 2'-5'-oligoadenylates (2-5A), potent activators of an important innate cellular antiviral pathway. 2H phosphoesterase superfamily proteins contain two conserved catalytic motifs and a proposed core structure. Here, we present structures of a viral 2H phosphoesterase, the rotavirus VP3 CTD, alone and in complex with its substrate, 2-5A. The domain lacks two alpha-helical regions and beta-strands present in other 2H phosphoesterases. A loop of the protein undergoes significant structural changes upon substrate binding. Together with our bioinformatics and biochemical findings, the crystal structures suggest that the RVA VP3 CTD domain is a streamlined version of a cellular enzyme that shares a ligand-binding mechanism with other 2H phosphodiesterases that cleave 2-5A but differs from those of 2H phosphodiesterases that cleave other substrates. These findings may aid in the future design of antivirals targeting viral phosphodiesterases with cleavage specificity for 2-5A.
引用
收藏
页码:6633 / 6645
页数:13
相关论文
共 50 条
  • [1] Functional characterization of 2′,5′-linked oligoadenylate binding determinant of human RNase L
    Nakanishi, M
    Tanaka, N
    Mizutani, Y
    Mochizuki, M
    Ueno, Y
    Nakamura, KT
    Kitade, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) : 41694 - 41699
  • [2] Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response
    Silverman, Robert H.
    JOURNAL OF VIROLOGY, 2007, 81 (23) : 12720 - 12729
  • [3] RNASE-L, A (2'-5')-OLIGOADENYLATE-DEPENDENT ENDORIBONUCLEASE - ASSAYS AND PURIFICATION OF THE ENZYME - CROSS-LINKING TO A (2'-5')-OLIGOADENYLATE DERIVATIVE
    FLOYDSMITH, G
    LENGYEL, P
    METHODS IN ENZYMOLOGY, 1986, 119 : 489 - 499
  • [4] The 2′-5′-Oligoadenylate Synthetase 3 Enzyme Potently Synthesizes the 2′-5′-Oligoadenylates Required for RNase L Activation
    Ibsen, Mikkel Soes
    Gad, Hans Henrik
    Thavachelvam, Karthiga
    Boesen, Thomas
    Despres, Philippe
    Hartmann, Rune
    JOURNAL OF VIROLOGY, 2014, 88 (24) : 14222 - 14231
  • [5] The role of 2'-5' oligoadenylate-activated RNase L in apoptosis.
    Castelli, J
    Hassel, B
    Wood, K
    Maran, A
    Paranjape, J
    Hewitt, J
    Li, X
    Hsu, Y
    Silverman, R
    Youle, R
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 179 - 179
  • [6] Skin allograft rejection is suppressed in mice lacking the antiviral enzyme, 2′,5′-oligoadenylate-dependent RNase L
    Silverman, RH
    Zhou, A
    Auerbach, MB
    Kish, D
    Gorbachev, A
    Fairchild, RL
    VIRAL IMMUNOLOGY, 2002, 15 (01) : 77 - 83
  • [7] The association of elevated 2′,5′-oligoadenylate-dependent RNase L with lung cancer correlated with deficient enzymatic activity and decreased capacity of RNase L dimerization
    Yin, Huijing
    Zhou, Aimin
    Dai, Yalei
    LUNG CANCER, 2012, 78 (01) : 30 - 38
  • [8] EFFECTS OF TEMPERATURE, AURINTRICARBOXYLIC ACID AND CIBACRON BLUE ON 2',5'-OLIGOADENYLATE BINDING-PROTEIN (RNASE-L) ACTIVITY IN RABBIT RETICULOCYTE LYSATES
    ESLAMI, BS
    KONNO, S
    WU, JM
    BIOCHEMISTRY INTERNATIONAL, 1986, 13 (01): : 163 - 171
  • [9] 2′,5′-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L
    Verheijen, JC
    van der Marel, GA
    van Boom, JH
    Bayly, SF
    Player, MR
    Torrence, PF
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (03) : 449 - 455
  • [10] The 2′-5′ oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation
    Bisbal, C
    Silhol, M
    Laubenthal, K
    Kaluza, T
    Carnac, G
    Milligan, L
    Le Roy, F
    Salehzada, T
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (14) : 4959 - 4969